Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Tobacco Treatment Program Implementation at NCI Cancer Centers: Progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative.

D'Angelo H, Rolland B, Adsit R, Baker TB, Rosenblum M, Pauk D, Morgan GD, Fiore MC.

Cancer Prev Res (Phila). 2019 Nov;12(11):735-740. doi: 10.1158/1940-6207.CAPR-19-0182. Epub 2019 Sep 3.

PMID:
31481540
2.

Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.

Carbone PP, Pirsch JD, Thomas JP, Douglas JA, Verma AK, Larson PO, Snow S, Tutsch KD, Pauk D.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):657-61.

3.

Bioavailability study of oral liquid and tablet forms of alpha-difluoromethylornithine.

Carbone PP, Douglas JA, Thomas J, Tutsch K, Pomplun M, Hamielec M, Pauk D.

Clin Cancer Res. 2000 Oct;6(10):3850-4.

4.

Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study.

Messing E, Pauk D, Schaeffer A, Nieweglowski M, Nyberg LM Jr, Landis JR, Cook YL, Simon LJ.

Urology. 1997 May;49(5A Suppl):81-5.

PMID:
9146006

Supplemental Content

Support Center